The variant upstream of ARMC9 that associates with vertigo (rs6753393-C, EAF = 26.6%, P = 4.6 × 10−11, OR = 1.06) associates with higher expression of ARMC9 (P = 6.1 × 10−21, effect = 0.55 SD) in adipose tissue. Here, ARMC9 is linked to Vertigo.